Teguh Haryo Sasongko
Dr Teguh Haryo Sasongko is currently the Deputy Director (Consultancy, Laboratory Services, and Business Development) at the Institute for Research, Development, and Innovations (IRDI), IMU University (IMU). He is also an Associate Professor at the Department of Physiology in IMU School of Medicine. He completed his medical training at the School of Medicine, Universitas Gadjah Mada, Indonesia in 2003. He obtained his doctoral degree in Medical Sciences from the Graduate School of Medicine, Kobe University, Japan in 2008 through a Japanese Government’s Monbukagakusho Scholarship.
He is an active author, trainer and reviewer for Cochrane, a prominent global initiative on evidence synthesis in healthcare. He is currently leading a national project in Cochrane Malaysia that aims at delivering Cochrane evidence to the public. He held several international visiting positions at the US (2012 – University of South Dakota), Japan (2016 - Japanese Society for the Promotion of Science (JSPS) at the Department of Biomedical Ethics and Public Policy, Osaka University), Indonesia (2022 – National Research and Innovation Agency), and United Kingdom (2025 - Global Forum on Bioethics in Research - University of St Andrews). He was one of the finalists of Mark S Ehrenreich Award during the 10th World Congress of Bioethics in 2010. He received an Author of the Year Award 2021 from The Conversation Indonesia. He was instrumental in formulating the ethical guidelines and template of informed consent form for human genetic and genomic research in Universiti Sains Malaysia as well as IMU University Policy on Intellectual Property and Commercialization of Research Inventions. He was a member of Medical and Health Sciences expert working group of the Malaysian Ministry of Science, Technology and Innovation that formulated the 7th Malaysian Research and Development Classification System (MRDCS) (2021). He was also part of the WHO Satellite Meeting that was formulating the WHO Guidance on Ethical Research Prioritization in Montreux, Switzerland (2023). He is advising the National Institutes of Health (NIH) at the Ministry of Health on the 13th Malaysia Plan Health Research Priorities, specifically focusing on rare diseases (2025).
He has a longstanding teaching, research, international publication as well as scientific reviewer portfolios in diverse biomedical fields, namely medical physiology, medical biochemistry and molecular genetics, medical and research ethics, as well as evidence-based healthcare.